MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.13828

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology.

Kotredes Kevin P, Pandey Ravi S, Persohn Scott, Elderidge Kierra, Burton Charles P, Miner Ethan W, Haynes Kathryn A, Santos Diogo Francisco S, Williams Sean-Paul, Heaton Nicholas, Ingraham Cynthia M, Lloyd Christopher, Garceau Dylan, O'Rourke Rita, Herrick Sarah, Rangel-Barajas Claudia, Maharjan Surendra, Wang Nian, Sasner Michael, Lamb Bruce T, Territo Paul R, Sukoff Rizzo Stacey J, Carter Gregory W, Howell Gareth R, Oblak Adrian L

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

MODEL-AD (Model Organism Development and Evaluation for Late-Onset Alzheimer's Disease) is creating and distributing novel mouse models with humanized, clinically relevant genetic risk factors to capture the trajectory and progression of late-onset Alzheimer's disease (LOAD) more accurately.

METHODS

We created the LOAD2 model by combining apolipoprotein E4 (APOE4), Trem2*R47H, and humanized amyloid-beta (Aβ). Mice were subjected to a control diet or a high-fat/high-sugar diet (LOAD2+HFD). We assessed disease-relevant outcome measures in plasma and brain including neuroinflammation, Aβ, neurodegeneration, neuroimaging, and multi-omics.

RESULTS

By 18 months, LOAD2+HFD mice exhibited sex-specific neuron loss, elevated insoluble brain Aβ42, increased plasma neurofilament light chain (NfL), and altered gene/protein expression related to lipid metabolism and synaptic function. Imaging showed reductions in brain volume and neurovascular uncoupling. Deficits in acquiring touchscreen-based cognitive tasks were observed.

DISCUSSION: The comprehensive characterization of LOAD2+HFD mice reveals that this model is important for preclinical studies seeking to understand disease trajectory and progression of LOAD prior to or independent of amyloid plaques and tau tangles.

HIGHLIGHTS: By 18 months, unlike control mice (e.g., LOAD2 mice fed a control diet, CD), LOAD2+HFD mice presented subtle but significant loss of neurons in the cortex, elevated levels of insoluble Ab42 in the brain, and increased plasma neurofilament light chain (NfL). Transcriptomics and proteomics showed changes in gene/proteins relating to a variety of disease-relevant processes including lipid metabolism and synaptic function. In vivo imaging revealed an age-dependent reduction in brain region volume (MRI) and neurovascular uncoupling (PET/CT). LOAD2+HFD mice also demonstrated deficits in acquisition of touchscreen-based cognitive tasks.

Для цитирования: Kotredes Kevin P, Pandey Ravi S, Persohn Scott, Elderidge Kierra, Burton Charles P, Miner Ethan W, Haynes Kathryn A, Santos Diogo Francisco S, Williams Sean-Paul, Heaton Nicholas, Ingraham Cynthia M, Lloyd Christopher, Garceau Dylan, O'Rourke Rita, Herrick Sarah, Rangel-Barajas Claudia, Maharjan Surendra, Wang Nian, Sasner Michael, Lamb Bruce T, Territo Paul R, Sukoff Rizzo Stacey J, Carter Gregory W, Howell Gareth R, Oblak Adrian L. Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024. DOI: 10.1002/alz.13828.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.